[Fibrinogen degradation products in gynecologic neoplasms].
Concentration of fibrinogen degradation products in sera of 12 healthy women and 163 patients with gynecological tumors was determined by Staphylococcal-clumping-test. In sera of healthy women and patients with benign tumors the highest titer was 8. On the other hand in 53 of 97 cases with malign tumors higher concentrations were evaluated.
D004715:Endometriosis / Q000097:blood; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000097:blood*; D005342:Fibrinolysis; D005833:Genital Neoplasms, Female / Q000097:blood*; D006801:Humans; D010051:Ovarian Neoplasms / Q000097:blood; D002583:Uterine Cervical Neoplasms / Q000097:blood; D014625:Vaginal Neoplasms / Q000097:blood; D014846:Vulvar Neoplasms / Q000097:blood
D005338:Fibrin Fibrinogen Degradation Products
Fibrinogen-Spaltprodukte bei gynäkologischen Tumoren